Clinical Trial Update: North Carolina Newborn Exome Sequencing for Universal Screening [NA]

View source ↗

Summary

A completed clinical trial from UNC Chapel Hill evaluating newborn exome sequencing for universal screening, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hearing Loss
• Hereditary Diseases
• Inborn Errors of Metabolism
• Metabolic Disorders

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Metabolism, Inborn Errors, Hearing Loss | NA | Status: COMPLETED | Results posted: 2020-07-08